Last reviewed · How we verify
Cromosan (MAGNESIUM ACETATE)
At a glance
| Generic name | MAGNESIUM ACETATE |
|---|---|
| Sponsor | Baxter |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
| First approval | 1979 |
Approved indications
Common side effects
- phlebitis
- thrombosis
- erythema
- warm sensation
- flushing
- fever
- nausea
Key clinical trials
- Pragmatic Pediatric Trial of Balanced Versus Normal Saline Fluid in Sepsis (PHASE3)
- Ringer Acetate Based Modified Del Nido Cardioplegia Solution Versus HTK Solution Cardioplegia Solution in Cardiac Surgery (PHASE3)
- Effect of Modifying Magnesium Concentration in Citrate-enriched Dialysate on Hemodialysis-associated Thromboinflammation (NA)
- Analysis of the Influence of Dialysis Fluid Composition on Vascular Calcification in Patients With Chronic Kidney Disease Undergoing Hemodialysis (NA)
- A Study to Evaluate a Postbiotic in Supporting Weight Loss and Metabolic Health (NA)
- Potential Therapeutic Role of Effervescent Calcium-Magnesium Citrate in Chronic Kidney Disease Stage V (PHASE2,PHASE3)
- Effect of Metformin, a Drug Used to Treat Diabetes, vs Placebo (PHASE4)
- Multiple Electrolytes Injection (II) and Normal Saline on Hyperchloremia in Severe Hemorrhagic Stroke (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |